Greischel A, Binder R, Baierl J
Regulatory Awareness: The GLP-1 telehealth and compounded medication industry has been under increased regulatory scrutiny
First-line treatment for MASLD includes a weight-reducing diet, increased physical activity levels, alcohol avoidance, and effective management of obesity, type 2 diabetes and other metabolic comorbidities
How We Evaluated This review was conducted using publicly available information and does not represent a clinical evaluation, endorsement, or recommendation
Polymeric nanoparticles, especially those derived from PLGA (poly(lactic-co-glycolic acid)), have been used to prepare long-acting formulations of GLP-1 that can extend the release period to weeks with a single dose, reducing injection frequency and improving patient adherence [33]